Coverage
-
April 20, 2023
Private equity firm ACAS LLC and two Travelers units told a Maryland federal court Thursday that they have resolved their dispute over coverage for an underlying wrongful death suit connected to a tainted batch of blood-thinning drug heparin.
3 other articles on this case.
View all »